CD4+ T cells of the Th1 subset are essential for effective anti-tumor immunity by their secretion of cytokines such as IFN-γ, which enhance DC function and T cell cytotoxicity, and support the licensing of DCs through CD40–CD40L interactions [72]. The gene discussed is CD4; the disease is neoplasm.